The interaction between nanoparticles and biological barriers

European Journal of Nanomedicine

Volumn 6, Issue 3, 2014, Pages 121-122

  Rocks, Louise ^a   Dawson, Kenneth A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

BIOLOGICAL BARRIER; EDITORIAL; HUMAN; MOLECULAR INTERACTION; NANOFABRICATION; NANOMEDICINE; PARTICLE SIZE; PERMEABILITY BARRIER; PUBLICATION;

EID: 84907507134     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2014-0029     Document Type: Editorial

References (7)

1. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol 2012;7:779-786.
2. Fabbrizi MR, Duff T, Oliver J, Wilde C. Advanced in vitro systems for efficacy and toxicity testing in Nanomedicine. Eur J Nanomed 2014;6:171-83.
3. Hudecz D, Rocks L, Fitzpatrick L, Herda L, Dawson KA. Reproducibility in biological models of the blood-brain barrier. Eur J Nanomed 2014;6:185-93.
4. Bramini M, Ye D, Hallerbach A, Nic Raghnaill M, Salvati A, Aberg C, et al. Imaging approach to mechanistic study of nanoparticle interactions. ACS Nano 2014;8:4304-12.
5. Herda L, Polo Tobajas E, Kelly P, Rocks L, Hudecz D, Dawson KA. Designing the future of nanomedicine: current barriers to targeted brain therapeutics. Eur J Nanomed 2014;6:127-39.
6. Casella C, Tuttolomondo M, Hilund-Carlsen PF, Mollenhauer J. Natural pattern recognition mechanisms at epithelial barriers and potential use in nanomedicine. Eur J Nanomed 2014;6:141-55.
7. Murgia X, de Souza Carvalho C, Lehr CM. Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics. Eur J Nanomed 2014;6:157-69.